DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $425,723 | -8.9% | 30,236 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $467,146 | -57.5% | 30,236 | -54.9% | 0.01% | -60.0% |
| Q4 2022 | $1,098,425 | -44.4% | 67,018 | -37.2% | 0.02% | -49.0% |
| Q3 2022 | $1,974,000 | +141.3% | 106,689 | +27.5% | 0.05% | +157.9% |
| Q4 2021 | $818,000 | -73.8% | 83,663 | -8.9% | 0.02% | -77.9% |
| Q3 2021 | $3,121,000 | +1114.4% | 91,843 | +1208.9% | 0.09% | +975.0% |
| Q2 2021 | $257,000 | -59.8% | 7,017 | -77.0% | 0.01% | -91.4% |
| Q4 2018 | $639,000 | +31.5% | 30,454 | +142.6% | 0.09% | +93.8% |
| Q3 2018 | $486,000 | – | 12,552 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |